| Organism | Setting of acquisition; no. (%) of organisms | |||
|---|---|---|---|---|
| Overall (n = 1416) | Community (n = 712) | Hospital (n = 266) | Intensive care unit (n = 438) | |
| Escherichia coli | 217 (15.3) | 147 (20.6) | 46 (17.3) | 24 (5.5) |
| Staphylococcus aureus | 175 (12.4) | 91 (12.8) | 28 (10.5) | 56 (12.8) |
| Enterococcus spp | 156 (11.0) | 34 (4.8) | 40 (15.0) | 82 (18.7) |
| Coagulase-negative staphylococci | 117 (8.3) | 44 (6.2) | 16 (6.0) | 57 (13.0) |
| Klebsiella spp | 108 (7.6) | 65 (9.1) | 22 (8.3) | 21 (4.8) |
| Candida spp | 94 (6.6) | 21 (2.9) | 22 (8.3) | 51 (11.6) |
| Streptococcus pneumoniae | 85 (6.0) | 81 (11.4) | 3 (1.1) | 1 (0.2) |
| Pseudomonas aeruginosa | 71 (5.0) | 18 (2.5) | 18 (6.8) | 35 (8.0) |
| Enterobacter spp | 51 (3.6) | 16 (2.2) | 10 (3.8) | 25 (5.7) |
| α-Hemolytic streptococci (viridans group) | 47 (3.3) | 29 (4.1) | 9 (3.4) | 9 (2.0) |
| β-Hemolytic Streptococcus: group A (pyogenes) | 26 (1.8) | 23 (3.2) | 1 (0.4) | 2 (0.4) |
| β-Hemolytic Streptococcus: group B (agalactiae) | 24 (1.7) | 18 (2.5) | 5 (1.9) | 1 (0.2) |
| Serratia marcescens | 24 (1.7) | 8 (1.1) | 1 (0.4) | 15 (3.4) |
| Strep. anginosus group | 20 (1.4) | 12 (1.7) | 3 (1.1) | 5 (1.1) |
| Bacteroides spp | 19 (1.3) | 11 (1.5) | 6 (2.2) | 2 (0.4) |
| Clostridium spp | 17 (1.2) | 9 (1.3) | 5 (1.9) | 3 (0.7) |
| Proteus spp | 17 (1.2) | 12 (1.7) | 2 (0.8) | 3 (0.7) |
| Stenotrophomonas maltophilia | 16 (1.1) | 3 (0.4) | 5 (1.9) | 8 (1.8) |
| Bacillus spp (aerobic spore-forming) | 13 (0.9) | 6 (0.8) | 3 (1.1) | 4 (0.9) |
| Acinetobacter spp | 9 (0.6) | 0 (0) | 2 (0.8) | 7 (1.6) |
| Morganella spp | 8 (0.6) | 3 (0.4) | 2 (0.8) | 3 (0.7) |
| Haemophilus influenzae | 7 (0.5) | 7 (1.0) | 0 (0) | 0 (0) |
| Prevotella spp | 6 (0.4) | 1 (0.1) | 2 (0.8) | 3 (0.7) |
| Other | 89 (6.3) | 53 (7.4) | 15 (5.6) | 21 (4.8) |